Hot Features
Premium
Level up your trading with our powerful tools and real-time insights all in one place.
Period:
Draw Mode:
| Volume | 173,975 |
|
|||||
| News | - | ||||||
| Day High | 3.825 | Low High |
|||||
| Day Low | 3.65 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Design Therapeutics Inc | DSGN | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.07 | 1.92% | 3.72 | 19:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 3.76 | 3.65 | 3.825 | 3.72 | 3.65 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 2,338 | 173,975 | US$ 3.74 | US$ 651,120 | - | 1.94 - 8.47 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 15:04:47 | formt | 4,409 | US$ 3.72 | USD |
Design Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 207.77M | 56.00M | - | 0 | -66.86M | -1.19 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Design Therapeutics News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical DSGN Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 3.77 | 3.94 | 3.51 | 3.65 | 142,732 | -0.05 | -1.33% |
| 1 Month | 3.52 | 4.125 | 3.45 | 3.76 | 270,971 | 0.20 | 5.68% |
| 3 Months | 2.29 | 4.145 | 2.245 | 3.35 | 271,954 | 1.43 | 62.45% |
| 6 Months | 2.11 | 4.145 | 1.96 | 2.73 | 337,996 | 1.61 | 76.30% |
| 1 Year | 6.84 | 8.47 | 1.94 | 3.01 | 463,694 | -3.12 | -45.61% |
| 3 Years | 26.15 | 29.16 | 1.94 | 8.43 | 327,501 | -22.43 | -85.77% |
| 5 Years | 28.00 | 50.00 | 1.94 | 8.90 | 324,353 | -24.28 | -86.71% |
Design Therapeutics Description
| Design Therapeutics Inc is a preclinical-stage biopharmaceutical company. It is a pioneering novel small-molecule therapeutic candidate, called gene-targeted chimera, that are designed to be disease-modifying and target the underlying cause of inherited nucleotide repeat expansion diseases. |
